Related Experiment Videos
Laparoscopic nephropexy: Washington University experience
O M Elashry1, S Y Nakada, E M McDougall
1Division of Urology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
The Journal of Urology
|November 1, 1995
Summary
Laparoscopic nephropexy effectively treated symptomatic nephroptosis in six patients, resolving kidney mobility and associated pain. This minimally invasive approach offers a safe and successful option for patients with this condition.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Nephrology
Background:
- Nephroptosis, or kidneyptosis, is a condition characterized by the abnormal downward displacement of a kidney.
- Symptomatic nephroptosis can cause significant flank pain, nausea, and other debilitating symptoms.
- Traditional surgical approaches for nephropexy can be invasive, carrying risks of complications and prolonged recovery.
Purpose of the Study:
- To evaluate the efficacy and safety of laparoscopic nephropexy for the treatment of symptomatic nephroptosis.
- To assess the anatomical and clinical outcomes of this minimally invasive surgical technique.
Main Methods:
- Six patients with symptomatic nephroptosis underwent laparoscopic right nephropexy.
- Surgical techniques involved securing Gerota's fascia or suturing the kidney to the quadratus lumborum muscle fascia.
- Additional fixation involved suturing the triangular ligament to the renal capsule for enhanced stability.
Main Results:
- Laparoscopic nephropexy was successful in all six patients, with no reported complications.
- Average operative time was 4 hours, with a mean hospital stay of 2.5 days.
- All patients experienced resolution of nephroptosis and remained asymptomatic for an average of 11 months post-surgery.
Conclusions:
- Laparoscopic nephropexy is a feasible, safe, and effective treatment for symptomatic nephroptosis.
- The procedure yields satisfactory anatomical and clinical results, offering a minimally invasive alternative.
- This technique provides a valuable option for managing patients suffering from documented, symptomatic kidneyptosis.